Today in News History

On July 12, several notable moments in the history of News stand out. In 1849, William Osler, Canadian physician and author (died 1919) was born. In 1888, Zygmunt Janiszewski, Polish mathematician and academic (died 1920) was born. In 1909, Herbert Zim, American naturalist, author, and educator (died 1994) was born. In 1948, Richard Simmons, American fitness trainer and actor (died 2024) was born. In 1954, Robert Carl, American pianist and composer was born. In 1955, Jimmy LaFave, American singer-songwriter and guitarist (died 2017) was born. In 1995, Jordyn Wieber, American gymnast was born. In 2001, Space Shuttle program: Space Shuttle Atlantis is launched on mission STS-104, carrying the Quest Joint Airlock to the International Space Station. In 2015, D'Army Bailey, American lawyer, judge, and actor (born 1941) passed away. In 2024, Ruth Westheimer, German-American sex therapist (born 1928) passed away. Together, these milestones provide historical context for today's news news and ongoing narratives.

Medicare will now cover weight-loss drugs like Wegovy and Zepbound for $50 in WA, OR, ID

KTTH – 770 AM – Seattle

KTTH – 770 AM – Seattle

·

July 1, 2026

·

right
Medicare will now cover weight-loss drugs like Wegovy and Zepbound for $50 in WA, OR, ID

Medicare's new GLP-1 Bridge covers Wegovy and Zepbound for 50 a month starting July 1 for eligible WA, OR, and ID seniors. Who qualifies and how long it lasts.

Narrative Intelligence Brief

This article was published by KTTH – 770 AM – Seattle, a source frequently categorized with a right bias based in United States of America. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of KTTH – 770 AM – Seattle, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.

Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.

How other outlets are covering this story

Compare narratives across 6 related reports from 6 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.

Coverage bias distribution

6 sources

Left 67%

Center 17%

Right 17%


The Independent

lean left

· Jun 29, 2026

Medicare will soon cover costs of weight-loss drugs. Here’s what you need to know

Popular Novo Nordisk and Eli Lilly drugs are included

FOX News Health

right

· Jul 1, 2026

Big Medicare change slashes weight-loss drug costs for eligible seniors

A new Medicare GLP-1 Bridge program offers Wegovy and Zepbound to eligible seniors for 50 a month starting July 1, slashing obesity drug costs.

NPR Topics: Health

lean left

· Jun 22, 2026

Trouble getting weight loss drugs covered by insurance? Here's what to know

What to do if your insurance denies your obesity drug.

Foreign Policy Journal

left

· Jul 1, 2026

Medicare Launches GLP-1 Bridge Program Covering Novo Nordisk (CPH: NOVO-B) And Eli Lilly (NYSE: LLY) Weight-Loss Drugs

Medicare is launching a temporary bridge program that will cover select GLP-1 weight-loss medications from two of the pharmaceutical industry’s largest players. The program will extend coverage to Novo Nordisk’s (CPH: NOVO-B) Wegovy, both in injection and tablet form, marking a significant shift in how the federal health program approaches obesity treatment. Eli Lilly’s (NYSE: [] The post Medicare Launches GLP-1 Bridge Program Covering Novo Nordisk (CPH: NOVO-B) And Eli Lilly (NYSE: LLY) Weight-Loss Drugs appeared first on Foreign Policy Journal.

Gizmodo

left

· Jul 8, 2026

11% of Americans Are Currently Taking a GLP-1 Weight Loss Drug Like Wegovy

15 of Americans have ever taken the drugs, up from 6 in 2024.

Hello Magazine

center

· Jul 6, 2026

I've been on GLP-1s for 16 months – here's why I won't be swapping to the new weight loss pill

Weight loss drug Wegovy is finally available in pill form, making it more accessible to people who want the benefits of GLP-1s – but is it worth making the swap?

Topics:

Health · 2
Entertainment · 2
World · 1
Unknown · 1

Related coverage for "Medicare will now cover weight-loss drugs like Wegovy and Zepbound for $50 in WA, OR, ID": The Independent — Medicare will soon cover costs of weight-loss drugs. Here’s what you need to know. FOX News Health — Big Medicare change slashes weight-loss drug costs for eligible seniors. NPR Topics: Health — Trouble getting weight loss drugs covered by insurance? Here's what to know. Foreign Policy Journal — Medicare Launches GLP-1 Bridge Program Covering Novo Nordisk (CPH: NOVO-B) And Eli Lilly (NYSE: LLY) Weight-Loss Drugs. Gizmodo — 11% of Americans Are Currently Taking a GLP-1 Weight Loss Drug Like Wegovy. Hello Magazine — I've been on GLP-1s for 16 months – here's why I won't be swapping to the new weight loss pill